This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tsuda, K. Articles by Goldstein, M. Search for Related Content PubMed PubMed Citation Articles by Tsuda, K. Articles by Goldstein, M.

Hypertension, Vol 14, 81-86, Copyright © 1989 by American Heart Association

ARTICLES

Neuropeptide Y and galanin in norepinephrine release in hypothalamic slices

K Tsuda, H Yokoo and M Goldstein
Neurochemistry Research Laboratories, New York University Medical Center, New York 10016.

Noradrenergic neurons in the locus ceruleus contain neuropeptide Y and galanin, which project to the hypothalamic region. We have investigated the regulatory mechanisms of these peptides on norepinephrine release in rat hypothalamic slices in vitro. Neuropeptide Y and galanin significantly inhibited the stimulation-evoked [3H]norepinephrine release in a dose-dependent manner (1 Hz: S2/S1 ratio (mean +/- SEM), control 0.947 +/- 0.040, n = 11, neuropeptide Y 1 x 10(-8) M 0.509 +/- 0.013, n = 8, p less than 0.01, neuropeptide Y 1 x 10(-7) M 0.283 +/- 0.021, n = 8, p less than 0.01; galanin 1 x 10(-7) M 0.448 +/- 0.026, n = 8, p less than 0.01, galanin 1 x 10(-6) M 0.261 +/- 0.023, n = 8, p less than 0.01). The inhibition of norepinephrine release by the alpha- 2 agonist UK 14,304 was potentiated by neuropeptide Y and galanin. The blockade of the alpha 2-adrenergic receptors by RX 781094 diminished the inhibitory effects of neuropeptide Y and galanin on norepinephrine release. Pretreatment of hypothalamic slices with islet activating protein (a toxin that interferes with the coupling of inhibitory receptors to adenylate cyclase) attenuated the suppression of norepinephrine release by UK 14,304, neuropeptide Y, and galanin. These results support the idea that neuropeptide Y and galanin are involved in the regulation of central adrenergic transmission partially mediated by alpha 2-adrenergic receptors and islet-activating protein-sensitive guanosine triphosphate-binding proteins in rat hypothalamus.

This article has been cited by other articles:

				T. Yoshitake, F.-H. Wang, E. Kuteeva, K. Holmberg, M. Yamaguchi, J. N. Crawley, R. Steiner, T. Bartfai, S. O. Ogren, T. Hokfelt, et al. Enhanced hippocampal noradrenaline and serotonin release in galanin-overexpressing mice after repeated forced swimming test PNAS, January 6, 2004; 101(1): 354 - 359. [Abstract] [Full Text] [PDF]

				K. Tsuda, M. Michalkiewicz, K. M. Knestaut, E. Yu. Bytchkova, and T. Michalkiewicz Neuropeptide Y and Sympathetic Nervous System in Blood Pressure Regulation * Response: Hypotension and Reduced Catecholamines in Neuropeptide Y Transgenic Rats Hypertension, November 1, 2003; 42 (5): e13 - e14. [Full Text] [PDF]

				D. Weinshenker, P. Szot, N. S. Miller, N. C. Rust, J. G. Hohmann, U. Pyati, S. S. White, and R. D. Palmiter Genetic Comparison of Seizure Control by Norepinephrine and Neuropeptide Y J. Neurosci., October 1, 2001; 21(19): 7764 - 7769. [Abstract] [Full Text] [PDF]

				M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy Prolactin: Structure, Function, and Regulation of Secretion Physiol Rev, October 1, 2000; 80(4): 1523 - 1631. [Abstract] [Full Text] [PDF]

				K. E. Smith, M. W. Walker, R. Artymyshyn, J. Bard, B. Borowsky, J. A. Tamm, W.-J. Yao, P. J.-J. Vaysse, T. A. Branchek, C. Gerald, et al. Cloned Human and Rat Galanin GALR3 Receptors. PHARMACOLOGY AND ACTIVATION OF G-PROTEIN INWARDLY RECTIFYING K+ CHANNELS J. Biol. Chem., September 4, 1998; 273(36): 23321 - 23326. [Abstract] [Full Text] [PDF]

				G. A. Kinney, P. J. Emmerson, and R. J. Miller Galanin Receptor-Mediated Inhibition of Glutamate Release in the Arcuate Nucleus of the Hypothalamus J. Neurosci., May 15, 1998; 18(10): 3489 - 3500. [Abstract] [Full Text] [PDF]